fda shortage tirzepatide news confirms is still over, gives compounders a grace period Tirzepatide is NO longer in – Mounjaro and Zepbound Are No – Tirzepatide may not be removed

The health benefits for infants, reduced infections, improved immune function, potential long-term metabolic benefits, are well established

More time and clinical studies are needed to determine whatever long-term health benefits and cost avoidance result from prescribing and covering these drugs for weight loss

Avoid repeated temperature cycling, and never freeze a reconstituted vial, which can precipitate the peptides out of solution

Semaglutide, other obesity drugs show potential to treat nondiabetic stroke GLP-1 receptor agonists such as semaglutide may be able to help reduce the risk of ischemic stroke in patients without diabetes, according to a new meta-analysis of preclinical studies published in Stroke .[1] These drugs have been linked to several key improvements in the cardiovascular health of patients with type 2 diabetes

A prospective study of dietary carotenoids, vitamins C and E, and risk of cataract in women